Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host
Ranjeet Singh, Mohammad Kashif, Prateek Srivastava, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 706-706
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Hayelom Berhe Dagnaw, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 227-227
Open Access | Times Cited: 5
Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study
Diksha Kumari, Parampreet Kour, Chetan Paul Singh, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132034-132034
Closed Access | Times Cited: 4
Key Facets for the Elimination of Vector-Borne Diseases Filariasis, Leishmaniasis, and Malaria
Rini Chaturvedi, Vitul Jain
ACS Infectious Diseases (2025) Vol. 11, Iss. 2, pp. 287-304
Closed Access
Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis
Priyanka H. Mazire, Snehal Shingade, Amit Roy
Experimental Parasitology (2025) Vol. 269, pp. 108898-108898
Closed Access
Zinc from an Essential Element to an Antiparasitic Therapeutic Agent
Maribel Navarro, Luana Vanessa Daniel, Legna Colina‐Vegas, et al.
ACS Omega (2025)
Open Access
Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection
Mirian França de Mello, Patrícia de Almeida Machado, Pollyane Sousa Gomes, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 129-129
Open Access
Novel Highly Sensitive and Specific Multiplex Real-Time Pcr Assay for Detection of Leishmania Donovani and Human Immunodeficiency Virus-1 Co-Infection
Moses Sanya, Victor A. Mobegi, Bernard Osero, et al.
(2025)
Closed Access
Exploring bioactive molecules released during inter- and intraspecific competition: A paradigm for novel antiparasitic drug discovery and design for human use
Pichet Ruenchit
Current Research in Parasitology and Vector-Borne Diseases (2025), pp. 100256-100256
Open Access
Novel Highly Sensitive and Specific Multiplex Real-Time PCR Assay for Detection of Leishmania donovani and Human Immunodeficiency Virus-1 Co-Infection
Moses Sanya, Victor A. Mobegi, Bernard Osero, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 112, Iss. 4, pp. 116860-116860
Closed Access
Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine
Bianca de Oliveira, Wanessa Goes, Frederico Crepaldi Nascimento, et al.
mSphere (2025)
Open Access
Treatment of Leishmania infantum Infections in Dogs
Melanie Kaempfle, Katrin Hartmann, Michèle Bergmann
Microorganisms (2025) Vol. 13, Iss. 5, pp. 1018-1018
Open Access
Intricate Role of Reactive Oxygen Species and Reactive Nitrogen Species in Leishmaniasis
R. S. Kaushal, Amit Kaushik, C. Ratna Prabha
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2025), pp. 269-310
Closed Access
Targeting Leishmania Promastigotes and Amastigotes Forms through Amino Acids and Peptides: A Promising Therapeutic Strategy
Charmante Registre, Luciana Miranda Silva, Farah Registre, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2467-2484
Closed Access | Times Cited: 2
Leishmania amazonensis-derived extracellular vesicles (EVs) induce neutrophil extracellular traps (NETs)
Gean Carlo Pereira‐Silva, Jorge Mansur Medina, Letícia Paschoaletto Dias, et al.
Journal of Leukocyte Biology (2024) Vol. 117, Iss. 1
Closed Access | Times Cited: 2
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents
Pasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15230-15255
Open Access | Times Cited: 6
Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin)
Simone S. C. Oliveira, Claudyane A. Correia, Vanessa S. Santos, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 7, pp. 348-348
Open Access | Times Cited: 4
Design, synthesis and identification of novel molecular hybrids based on naphthoquinone aromatic hydrazides as potential trypanocide and leishmanicidal agents
Rosane Dias Cezar, Adriano Olímpio da Silva, Rosângela da Silva Lopes, et al.
Anais da Academia Brasileira de Ciências (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 1
Transcriptome and proteome changes triggered by overexpression of the transcriptional regulator Maf1 in the human pathogen Leishmania major
Luis Alberto Rivera-Rivas, Luis E. Florencio‐Martínez, Gabriela Romero‐Meza, et al.
The FASEB Journal (2024) Vol. 38, Iss. 16
Open Access | Times Cited: 1
Synergistic Effects of Artesunate in Combination with Amphotericin B and Miltefosine against Leishmania infantum: Potential for Dose Reduction and Enhanced Therapeutic Strategies
Nuchpicha Intakhan, Atiporn Saeung, Sonia M. Rodrigues Oliveira, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 806-806
Open Access | Times Cited: 1
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Nir Qvit, Mulate Zerihun, Mahesh Kumar, et al.
(2023)
Open Access | Times Cited: 1
Challenges in drug discovery and description targeting Leishmania spp.: enzymes, structural proteins, and transporters
Alexis Mendoza-León, María Luisa Serrano G., Alicia Ponte‐Sucre
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 1
In silico prediction of CD8+ and CD4+ T cell epitopes in Leishmania major proteome: Using immunoinformatics
Mohammad Kashif, Mohd Waseem, Naidu Subbarao
Journal of Molecular Graphics and Modelling (2024) Vol. 129, pp. 108759-108759
Closed Access
In Vitro Assessment of Dracocephalum lindbergii for Growth Inhibition, Apoptosis Induction, and Cytokine Modulation Against Leishmania major
Faham Khamesipour, Ali Khamesipour, Seyed Hossein Hejazi, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38331-e38331
Open Access
Antiprotozoal Natural Products from Endophytic Fungi Associated with Cacao and Coffee
Cristopher A. Boya P., Candelario Rodríguez, Randy Mojica-Flores, et al.
Metabolites (2024) Vol. 14, Iss. 11, pp. 575-575
Open Access
Analyses of the essential C82 subunit uncovered some differences in RNA polymerase III transcription between Trypanosoma brucei and Leishmania major
Andrés Cano-Santiago, Luis E. Florencio‐Martínez, Daniel E. Vélez‐Ramírez, et al.
Parasitology (2024), pp. 1-16
Open Access
Page 1 - Next Page

Scroll to top